Otolaryngology Doctors in New Iberia, LA Accepting Medicare

7 Otolaryngology doctors found. Showing 1 - 7

James C Walker, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2312 E Main St, St. A St., New Iberia, LA 70560 Phone: 337-364-9681    Fax: 337-367-9697

Charles A Moore, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2308 E Main St Ste B, New Iberia, LA 70560 Phone: 337-369-3683

Lizabeth F Clarke, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 426 Charles St, New Iberia, LA 70560 Phone: 337-365-4156    Fax: 337-365-4192

Harold G Bienvenu Iii, M.D. Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 426 Charles St, New Iberia, LA 70560 Phone: 337-365-4156    Fax: 337-365-4095

Dr. Clyde Edward Landrum, M.D. Otolaryngology - Facial Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 41 Shadows Bend, New Iberia, LA 70563 Phone: 337-519-3399    Fax: 337-369-6829

Monty Joseph Rizzo, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1100 Andre St, Ste 100, New Iberia, LA 70563 Phone: 337-365-3541    Fax: 337-365-0863

Tynes Emery Mixon Iii, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 426 Charles St, New Iberia, LA 70560 Phone: 337-365-4156    Fax: 337-365-4192

News Archive

Report: Postmastectomy pain rated as most troubling symptom by breast cancer survivors

More than 40 percent of 200,000 U.S. women diagnosed with breast cancer every year undergo surgery. Though treatment advances have significantly reduced mortality from breast cancer, a study published in The Journal of Pain reported that persistent postmastectomy pain is rated by survivors as their most troubling symptom. The Journal of Pain is published by the American Pain Society, www.americanpainsociety.org.

TxCell demonstrates therapeutic potential of Col-Treg for treatment of autoimmune uveitis

TxCell SA, a biotechnology company developing innovative, economically viable, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that TxCell researchers have achieved positive results for Col-Treg, its second product candidate from its ASTrIA platform, in a model of autoimmune uveitis, a leading cause of blindness with very limited treatment options.

Synergetics launches next generation of Codman Malis electrosurgical generator

Synergetics USA, Inc., a medical device company that designs, manufactures, and markets innovative products for ophthalmic and neurosurgical applications, has introduced the CMC® V, the next generation of the Codman® Malis® electrosurgical generator. Codman & Shurtleff, Inc. is the exclusive distributor of the CMC® V. CMC and Codman are registered trademarks of Johnson & Johnson Corporation.

Women and men more likely to have another major cardiovascular event after stroke

New research from Western University has shown that both women and men are significantly more likely to have a heart attack or another major cardiovascular event within thirty days of having a stroke.

Read more Medical News

› Verified 4 days ago